Michelle A. Hodges - 31 Jan 2025 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Chief Legal Officer
Signature
/s/ Jennifer Ahn, attorney-in-fact for Michelle A. Hodges
Issuer symbol
QDEL
Transactions as of
31 Jan 2025
Net transactions value
-$67,276
Form type
4
Filing time
04 Feb 2025, 16:17:07 UTC
Previous filing
31 Jan 2025
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award $0 +1,610 +9.4% $0.000000 18,789 31 Jan 2025 Direct F1, F2
transaction QDEL Common Stock Tax liability $28,771 -662 -3.5% $43.46 18,127 31 Jan 2025 Direct F3
transaction QDEL Common Stock Award $0 +1,814 +10% $0.000000 19,941 31 Jan 2025 Direct F1
transaction QDEL Common Stock Tax liability $31,161 -717 -3.6% $43.46 19,224 31 Jan 2025 Direct F3
transaction QDEL Common Stock Award $0 +474 +2.5% $0.000000 19,698 01 Feb 2025 Direct F1
transaction QDEL Common Stock Tax liability $7,345 -169 -0.86% $43.46 19,529 01 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units Options Exercise $0 -1,610 -50% $0.000000 1,610 31 Jan 2025 Common Stock 1,610 Direct F4, F5
transaction QDEL Restricted Stock Units Options Exercise $0 -1,814 -50% $0.000000 1,814 31 Jan 2025 Common Stock 1,814 Direct F4, F6
transaction QDEL Restricted Stock Units Options Exercise $0 -474 -100% $0.000000 0 01 Feb 2025 Common Stock 474 Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted units that were previously reported on a Form 4.
F2 The amount of shares beneficially owned following this transaction includes an additional 512 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
F3 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F4 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F5 1,610 shares vested on January 31, 2025; the remaining 1,610 shares will vest on January 31, 2026.
F6 1,814 shares vested on January 31, 2025; the remaining 1,814 shares will vest on January 31, 2026.
F7 474 shares vested on January 31, 2025.